Safety and Dose-escalation Study of AAV2-hCHM in Participants With CHM (Choroideremia) Gene Mutations
Clinical trial NCT02341807 · COMPLETED
Trial details
- NCT number
- NCT02341807
- Sponsor
- Spark Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-15
- Primary completion
- 2022-10-12
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.